Utama › Lupus
Kajian klinikal Lupus sedang mengambil peserta di AS
73 kajian untuk Lupus sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- New York City, NY18 kajian
- Houston, TX13 kajian
- Durham, NC12 kajian
- Washington, DC10 kajian
- Miami, FL10 kajian
- Tampa, FL9 kajian
- Philadelphia, PA9 kajian
- Clearwater, FL8 kajian
- Santa Monica, CA8 kajian
- Oklahoma City, OK8 kajian
- Boston, MA8 kajian
- Los Angeles, CA8 kajian
- Chicago, IL8 kajian
- Memphis, TN7 kajian
- San Diego, CA7 kajian
- Buena Park, CA7 kajian
- Charlotte, NC7 kajian
- Plantation, FL7 kajian
- Aurora, CO6 kajian
- Hollywood, FL6 kajian
- Dallas, TX6 kajian
- Cedar Rapids, IA6 kajian
- Atlanta, GA6 kajian
- Cicero, IL5 kajian
- Lake Charles, LA5 kajian
- Cleveland, OH5 kajian
- New Orleans, LA5 kajian
- Fullerton, CA5 kajian
- Jackson, TN5 kajian
- St. Louis, MO5 kajian
- Orlando, FL5 kajian
- Syracuse, NY5 kajian
- Coral Springs, FL4 kajian
- Flint, MI4 kajian
- Rochester, NY4 kajian
- Allen, TX4 kajian
- Arlington, TX4 kajian
- Phoenix, AZ4 kajian
- Louisville, KY4 kajian
- Brandon, FL4 kajian
Mengikut negeri
- Alabama5 kajian
- Arizona7 kajian
- California27 kajian
- Colorado8 kajian
- Florida23 kajian
- Georgia9 kajian
- Illinois14 kajian
- Indiana4 kajian
- Iowa6 kajian
- Kansas5 kajian
- Kentucky4 kajian
- Louisiana9 kajian
- Maryland10 kajian
- Massachusetts9 kajian
- Michigan10 kajian
- Minnesota5 kajian
- Missouri8 kajian
- Nebraska3 kajian
- New Jersey6 kajian
- New York26 kajian
- North Carolina20 kajian
- Ohio11 kajian
- Oklahoma8 kajian
- Pennsylvania14 kajian
- South Carolina5 kajian
- Tennessee13 kajian
- Texas26 kajian
- Utah4 kajian
- Virginia3 kajian
- Washington5 kajian
- Wilayah Columbia5 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Mengambil pesertaFasa 3
Umur 16 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06617325Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Mengambil pesertaFasa 2
Umur 18 hingga 100 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05268289A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Mengambil pesertaFasa 2
Umur 18 hingga 74 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07409181Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Mengambil pesertaFasa 3
Umur 12 hingga 100 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06133972An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Mengambil pesertaFasa 3
Umur 5 hingga 17 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT05835310Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 120 · Wanita · Dikemas kini 28 Sep 2026 · NCT05567198A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Mengambil pesertaFasa 3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07430306A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07438496A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
Mengambil pesertaFasa 1
Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07607964CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
Mengambil pesertaFasa 1/2
Umur 10 hingga 29 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06839976Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT03816345Anifrolumab Pregnancy Study
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 130 · Wanita · Dikemas kini 18 Sep 2026 · NCT07049653The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 18 Sep 2026 · NCT05440422Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Mengambil pesertaFasa 1
Umur 18 hingga 65 · Semua jantina · Dikemas kini 18 Sep 2026 · NCT07201558A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
Mengambil pesertaFasa 2
Umur 16 hingga 70 · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07328581Transcutaneous Vagus Nerve Stimulation in SLE
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06987565Study of Systemic Lupus Erythematosus
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 3 hingga 120 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT00001372HEALTH Home Urinalysis Testing
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07823478Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
Mengambil pesertaFasa 4
Umur 18 hingga 130 · Wanita · Dikemas kini 16 Sep 2026 · NCT06594068A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Mengambil pesertaFasa 1
Umur 18 hingga 70 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06916806Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Mengambil pesertaFasa 1
Umur 18 hingga 60 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06975787A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07355218A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
Mengambil pesertaFasa 2
Umur 12 hingga 70 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07570862A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07332481A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
Mengambil pesertaFasa 1/2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06897930Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.